BEACON INVESTMENT ADVISORY SERVICES, INC.
Position in OGN — Organon & Co.
CIK 1654599
MORRISTOWN, NJ
Position in OGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$5,754
+$3,209 QoQ
Shares Held
425
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#364
of 626 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BEACON INVESTMENT ADVISORY SERVICES, INC. holds $137,808,603 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
104,988 | $38,018,254 | |
| 2 | JNJ |
Johnson & Johnson
|
112,400 | $28,546,228 | |
| 3 | ABBV |
AbbVie Inc.
|
84,475 | $21,257,289 | |
| 4 | LLY |
ELI LILLY & Co
|
17,158 | $20,579,821 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
112,362 | $14,195,815 | |
| 6 | NVO |
Novo Nordisk A S
|
145,810 | $6,990,131 | |
| 7 | MRK |
Merck & Co., Inc.
|
25,298 | $3,250,793 | |
| 8 | BIIB |
Biogen Inc.
|
12,229 | $2,642,197 |
All Filings in OGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,754 | 425 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,545 | 425 | Shares | Sole | 2026-04-14 | |
| No filing history on record for this holder in this stock. | ||||||